Laboratory Medicine ›› 2016, Vol. 31 ›› Issue (8): 640-646.DOI: 10.3969/j.issn.1673-8640.2016.08.002
• Orginal Article • Previous Articles Next Articles
LI Xin, WANG Di, YANG Chun, XU Jiancheng
Received:2015-11-19
Online:2016-08-31
Published:2016-09-01
CLC Number:
LI Xin, WANG Di, YANG Chun, XU Jiancheng. Reference intervals of serum bilirubin for Han children in Changchun[J]. Laboratory Medicine, 2016, 31(8): 640-646.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2016.08.002
| 年龄(岁) | 例数 | 男童 | 女童 |
|---|---|---|---|
| <1 | 240 | 120 | 120 |
| 1~ | 253 | 131 | 122 |
| 2~ | 247 | 127 | 120 |
| 3~ | 246 | 120 | 126 |
| 4~ | 247 | 127 | 120 |
| 5~ | 246 | 120 | 126 |
| 6~ | 250 | 124 | 126 |
| 7~ | 251 | 129 | 122 |
| 8~ | 252 | 132 | 120 |
| 9~ | 248 | 128 | 120 |
| 10~ | 249 | 129 | 120 |
| 11~ | 252 | 127 | 125 |
| 12~ | 250 | 120 | 130 |
| 13~ | 245 | 123 | 122 |
| 14~ | 240 | 120 | 120 |
| 合计 | 3 716 | 1 877 | 1 839 |
| 年龄(岁) | 例数 | 男童 | 女童 |
|---|---|---|---|
| <1 | 240 | 120 | 120 |
| 1~ | 253 | 131 | 122 |
| 2~ | 247 | 127 | 120 |
| 3~ | 246 | 120 | 126 |
| 4~ | 247 | 127 | 120 |
| 5~ | 246 | 120 | 126 |
| 6~ | 250 | 124 | 126 |
| 7~ | 251 | 129 | 122 |
| 8~ | 252 | 132 | 120 |
| 9~ | 248 | 128 | 120 |
| 10~ | 249 | 129 | 120 |
| 11~ | 252 | 127 | 125 |
| 12~ | 250 | 120 | 130 |
| 13~ | 245 | 123 | 122 |
| 14~ | 240 | 120 | 120 |
| 合计 | 3 716 | 1 877 | 1 839 |
| 年龄 (岁) | 性别 | P2.5 (90% CI) | P50 (90% CI) | P97.5 (90% CI) | 年龄 (岁) | 性别 | P2.5 (90% CI) | P50 (90% CI) | P97.5 (90% CI) |
|---|---|---|---|---|---|---|---|---|---|
| <1 | 男 | 1.90(1.56~2.24) | 4.75(4.10~5.10) | 10.20(9.31~10.89) | 7~ | 女 | 2.85(2.63~4.17) | 7.50(6.98~8.02) | 14.59(13.73~15.07) |
| 女 | 1.80(1.18~2.42) | 5.60(4.93~6.07) | 13.04(1.97~15.03) | 8~ | 男 | 2.70(2.54~3.26) | 7.40(6.71~8.09) | 16.44(13.52~17.88) | |
| 1~ | 男 | 2.20(1.99~2.41) | 5.10(4.80~5.40) | 11.67(10.86~12.34) | 女 | 3.81(3.08~4.52) | 8.35(7.69~8.91) | 21.00(16.29~25.31) | |
| 女 | 2.42(2.37~2.83) | 5.75(5.18~6.22) | 12.96(11.04~13.96) | 9~ | 男 | 3.50(3.23~3.77) | 7.15(6.27~7.73) | 14.51(13.14~15.26) | |
| 2~ | 男 | 2.58(2.54~3.26) | 6.00(5.47~6.53) | 12.36(10.57~13.03) | 女 | 3.27(2.56~4.04) | 8.60(8.20~9.00) | 16.73(15.33~18.07) | |
| 女 | 2.51(1.94~3.06) | 6.55(5.78~7.22) | 16.39(13.37~18.43) | 10~ | 男 | 3.28(2.81~4.19) | 8.00(7.61~8.39) | 15.10(13.93~15.67) | |
| 3~ | 男 | 2.31(1.53~3.07) | 5.80(5.46~6.14) | 11.19(9.81~11.59) | 女 | 3.10(2.69~3.51) | 8.10(7.11~8.89) | 17.29(14.37~19.63) | |
| 年龄 (岁) | 性别 | P2.5 (90% CI) | P50 (90% CI) | P97.5 (90% CI) | 年龄 (岁) | 性别 | P2.5 (90% CI) | P50 (90% CI) | P97.5 (90% CI) |
| 女 | 2.65(2.35~3.45) | 6.50(5.89~7.11) | 15.08(12.71~16.29) | 11~ | 男 | 2.92(2.22~3.78) | 7.60(6.98~8.22) | 17.92(14.78~20.42) | |
| 4~ | 男 | 2.60(2.43~2.77) | 5.90(5.67~6.13) | 12.44(11.20~13.20) | 女 | 3.33(2.99~4.01) | 8.20(7.87~8.53) | 16.17(14.86~17.14) | |
| 女 | 2.70(2.17~3.23) | 6.60(5.94~7.26) | 17.15(12.38~17.82) | 12~ | 男 | 3.90(2.98~4.82) | 8.35(7.30~9.10) | 19.87(16.41~20.99) | |
| 5~ | 男 | 3.00(2.60~3.40) | 5.90(5.54~6.26) | 11.09(9.58~11.82) | 女 | 1.88(1.36~2.84) | 8.70(7.64~9.56) | 19.77(18.28~21.12) | |
| 女 | 3.52(3.12~4.08) | 6.25(5.77~6.63) | 12.51(11.39~12.81) | 13~ | 男 | 1.55(1.35~2.65) | 8.10(7.20~9.00) | 21.34(16.63~24.97) | |
| 6~ | 男 | 3.03(2.92~3.48) | 6.30(5.70~6.90) | 12.25(9.85~12.55) | 女 | 2.00(1.76~2.24) | 6.60(5.78~7.22) | 15.86(14.28~16.32) | |
| 女 | 3.52(3.08~4.12) | 7.80(7.20~8.20) | 16.48(14.65~17.15) | 14~ | 男 | 1.50(1.10~1.90) | 8.20(7.32~8.88) | 19.08(15.58~20.82) | |
| 7~ | 男 | 2.95(2.74~3.46) | 6.70(6.18~7.22) | 15.43(12.51~17.89) | 女 | 2.05(1.43~2.77) | 6.60(6.10~7.10) | 13.60(12.85~14.35) |
| 年龄 (岁) | 性别 | P2.5 (90% CI) | P50 (90% CI) | P97.5 (90% CI) | 年龄 (岁) | 性别 | P2.5 (90% CI) | P50 (90% CI) | P97.5 (90% CI) |
|---|---|---|---|---|---|---|---|---|---|
| <1 | 男 | 1.90(1.56~2.24) | 4.75(4.10~5.10) | 10.20(9.31~10.89) | 7~ | 女 | 2.85(2.63~4.17) | 7.50(6.98~8.02) | 14.59(13.73~15.07) |
| 女 | 1.80(1.18~2.42) | 5.60(4.93~6.07) | 13.04(1.97~15.03) | 8~ | 男 | 2.70(2.54~3.26) | 7.40(6.71~8.09) | 16.44(13.52~17.88) | |
| 1~ | 男 | 2.20(1.99~2.41) | 5.10(4.80~5.40) | 11.67(10.86~12.34) | 女 | 3.81(3.08~4.52) | 8.35(7.69~8.91) | 21.00(16.29~25.31) | |
| 女 | 2.42(2.37~2.83) | 5.75(5.18~6.22) | 12.96(11.04~13.96) | 9~ | 男 | 3.50(3.23~3.77) | 7.15(6.27~7.73) | 14.51(13.14~15.26) | |
| 2~ | 男 | 2.58(2.54~3.26) | 6.00(5.47~6.53) | 12.36(10.57~13.03) | 女 | 3.27(2.56~4.04) | 8.60(8.20~9.00) | 16.73(15.33~18.07) | |
| 女 | 2.51(1.94~3.06) | 6.55(5.78~7.22) | 16.39(13.37~18.43) | 10~ | 男 | 3.28(2.81~4.19) | 8.00(7.61~8.39) | 15.10(13.93~15.67) | |
| 3~ | 男 | 2.31(1.53~3.07) | 5.80(5.46~6.14) | 11.19(9.81~11.59) | 女 | 3.10(2.69~3.51) | 8.10(7.11~8.89) | 17.29(14.37~19.63) | |
| 年龄 (岁) | 性别 | P2.5 (90% CI) | P50 (90% CI) | P97.5 (90% CI) | 年龄 (岁) | 性别 | P2.5 (90% CI) | P50 (90% CI) | P97.5 (90% CI) |
| 女 | 2.65(2.35~3.45) | 6.50(5.89~7.11) | 15.08(12.71~16.29) | 11~ | 男 | 2.92(2.22~3.78) | 7.60(6.98~8.22) | 17.92(14.78~20.42) | |
| 4~ | 男 | 2.60(2.43~2.77) | 5.90(5.67~6.13) | 12.44(11.20~13.20) | 女 | 3.33(2.99~4.01) | 8.20(7.87~8.53) | 16.17(14.86~17.14) | |
| 女 | 2.70(2.17~3.23) | 6.60(5.94~7.26) | 17.15(12.38~17.82) | 12~ | 男 | 3.90(2.98~4.82) | 8.35(7.30~9.10) | 19.87(16.41~20.99) | |
| 5~ | 男 | 3.00(2.60~3.40) | 5.90(5.54~6.26) | 11.09(9.58~11.82) | 女 | 1.88(1.36~2.84) | 8.70(7.64~9.56) | 19.77(18.28~21.12) | |
| 女 | 3.52(3.12~4.08) | 6.25(5.77~6.63) | 12.51(11.39~12.81) | 13~ | 男 | 1.55(1.35~2.65) | 8.10(7.20~9.00) | 21.34(16.63~24.97) | |
| 6~ | 男 | 3.03(2.92~3.48) | 6.30(5.70~6.90) | 12.25(9.85~12.55) | 女 | 2.00(1.76~2.24) | 6.60(5.78~7.22) | 15.86(14.28~16.32) | |
| 女 | 3.52(3.08~4.12) | 7.80(7.20~8.20) | 16.48(14.65~17.15) | 14~ | 男 | 1.50(1.10~1.90) | 8.20(7.32~8.88) | 19.08(15.58~20.82) | |
| 7~ | 男 | 2.95(2.74~3.46) | 6.70(6.18~7.22) | 15.43(12.51~17.89) | 女 | 2.05(1.43~2.77) | 6.60(6.10~7.10) | 13.60(12.85~14.35) |
| 年龄 (岁) | 例数 | TBil(µmol/L) | CBil(µmol/L) | UBil(µmol/L) | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 参考区间 | 90%CI | 参考区间 | 90%CI | 参考区间 | 90%CI | |||||||
| P2.5 | P97.5 | P2.5 | P97.5 | P2.5 | P97.5 | |||||||
| <1 | 240 | 1.90~11.33 | 1.52~2.28 | 9.82~12.78 | 0.90~3.41 | 0.79~1.01 | 3.00~3.80 | 0.60~9.31 | 0.31~0.89 | 8.16~10.44 | ||
| 1 | 253 | 2.34~12.03 | 2.22~2.58 | 11.29~12.51 | 0.84~3.30 | 0.72~1.08 | 3.08~3.52 | 1.17~8.70 | 0.93~1.67 | 8.12~9.28 | ||
| 2~5及 6(男) | 1 110 | 2.80~12.82 | 2.64~2.96 | 12.28~13.32 | 1.00~3.60 | 0.94~1.06 | 3.45~3.75 | 1.60~9.72 | 1.52~1.68 | 9.16~10.24 | ||
| 6(女) 及7 | 377 | 3.25~15.37 | 3.02~4.58 | 14.30~16.10 | 0.95~4.46 | 0.84~1.16 | 4.11~4.69 | 1.80~11.25 | 1.60~2.00 | 10.30~12.10 | ||
| 8~11 | 1 001 | 3.20~16.60 | 2.95~3.45 | 16.01~17.19 | 1.20~4.70 | 1.12~1.28 | 4.45~4.95 | 1.80~12.20 | 1.66~1.94 | 11.62~12.78 | ||
| 12 | 250 | 2.41~19.77 | 1.71~3.69 | 18.48~20.92 | 1.10~5.17 | 0.91~1.29 | 4.90~5.30 | 1.16~14.95 | 0.62~1.98 | 13.97~15.63 | ||
| 13~14 | 485 | 1.80~16.33 | 1.49~2.11 | 14.44~18.16 | 0.90~4.60 | 0.81~0.99 | 4.44~4.76 | 0.70~12.62 | 0.46~0.94 | 10.92~14.28 | ||
| 年龄 (岁) | 例数 | TBil(µmol/L) | CBil(µmol/L) | UBil(µmol/L) | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 参考区间 | 90%CI | 参考区间 | 90%CI | 参考区间 | 90%CI | |||||||
| P2.5 | P97.5 | P2.5 | P97.5 | P2.5 | P97.5 | |||||||
| <1 | 240 | 1.90~11.33 | 1.52~2.28 | 9.82~12.78 | 0.90~3.41 | 0.79~1.01 | 3.00~3.80 | 0.60~9.31 | 0.31~0.89 | 8.16~10.44 | ||
| 1 | 253 | 2.34~12.03 | 2.22~2.58 | 11.29~12.51 | 0.84~3.30 | 0.72~1.08 | 3.08~3.52 | 1.17~8.70 | 0.93~1.67 | 8.12~9.28 | ||
| 2~5及 6(男) | 1 110 | 2.80~12.82 | 2.64~2.96 | 12.28~13.32 | 1.00~3.60 | 0.94~1.06 | 3.45~3.75 | 1.60~9.72 | 1.52~1.68 | 9.16~10.24 | ||
| 6(女) 及7 | 377 | 3.25~15.37 | 3.02~4.58 | 14.30~16.10 | 0.95~4.46 | 0.84~1.16 | 4.11~4.69 | 1.80~11.25 | 1.60~2.00 | 10.30~12.10 | ||
| 8~11 | 1 001 | 3.20~16.60 | 2.95~3.45 | 16.01~17.19 | 1.20~4.70 | 1.12~1.28 | 4.45~4.95 | 1.80~12.20 | 1.66~1.94 | 11.62~12.78 | ||
| 12 | 250 | 2.41~19.77 | 1.71~3.69 | 18.48~20.92 | 1.10~5.17 | 0.91~1.29 | 4.90~5.30 | 1.16~14.95 | 0.62~1.98 | 13.97~15.63 | ||
| 13~14 | 485 | 1.80~16.33 | 1.49~2.11 | 14.44~18.16 | 0.90~4.60 | 0.81~0.99 | 4.44~4.76 | 0.70~12.62 | 0.46~0.94 | 10.92~14.28 | ||
| [1] | 王建中. 实验诊断学[M]. 2版. 北京:北京大学医学出版社,2010:155-157. |
| [2] | CERIOTTI F,HENNY J,QUERALTO J,et al.Common reference intervals for aspartate aminotransferase (AST),alanine aminotransferase (ALT) and γ-glutamyl transferase (GGT) in serum:results from an IFCC multicenter study[J]. Clin Chem Lab Med,2010,48(11):1593-1601. |
| [3] | Clinical and Laboratory Standards Institute,International Federation of Clinical Chemistry and Laboratory Medicine. Defining,establishing,and verifying the reference intervals in a clinical laboratory[S]. C28-A3,CLSI and IFCC,2008. |
| [4] | COLANTONIO DA,KYRIAKOPOULOU L,CHAN MK,et al.Closing the gaps in pediatric laboratory reference intervals:a CALIPER database of 40 biochemical markers in a healthy and multiethnic population of children[J]. Clin Chem,2012,58(5):854-868. |
| [5] | MU R,CHEN W,PAN B,et al.First definition of reference intervals of liver function tests in China:a large-population-based multi-center study about healthy adults[J]. PLoS One,2013,8(9):e72916. |
| [6] | BLASUTIG IM,JUNG B,KULASINGAM V,et al.Analytical evaluation of the VITROS 5600 Integrated System in a pediatric setting and determination of pediatric reference intervals[J]. Clin Biochem,2010,43(13-14):1039-1044. |
| [7] | KULASINGAM V,JUNG BP,BLASUTIG IM,et al.Pediatric reference intervals for 28 chemistries and immunoassays on the Roche cobas 6000 analyzer-a CALIPER pilot study[J]. Clin Biochem,2010,43(13-14):1045-1050. |
| [8] | 陈大鹏,陈元,刘来成,等. 重庆地区学龄前和学龄后健康儿童常用肝肾功能检验项目参考区间的调查[J]. 重庆医科大学学报,2015,40(5):785-789. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||